CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 116 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $152,634,215 | +59.9% | 5,132,287 | -3.1% | 1.98% | +64.6% |
| Q2 2023 | $95,471,546 | +12.4% | 5,298,088 | +0.2% | 1.20% | +1.1% |
| Q1 2023 | $84,949,675 | -17.5% | 5,289,519 | -6.0% | 1.19% | -22.3% |
| Q4 2022 | $102,932,815 | -6.9% | 5,624,744 | -0.1% | 1.54% | -8.4% |
| Q3 2022 | $110,612,000 | +8.3% | 5,631,958 | +2.9% | 1.68% | +1.3% |
| Q2 2022 | $102,099,000 | -5.9% | 5,474,459 | +10.7% | 1.65% | +24.1% |
| Q1 2022 | $108,521,000 | -20.3% | 4,944,013 | +3.1% | 1.33% | -4.1% |
| Q4 2021 | $136,187,000 | +115.8% | 4,793,638 | +59.9% | 1.39% | +85.8% |
| Q3 2021 | $63,119,000 | +23.7% | 2,998,512 | +10.7% | 0.75% | +10.7% |
| Q2 2021 | $51,043,000 | +66.7% | 2,707,825 | +35.1% | 0.68% | +49.6% |
| Q1 2021 | $30,616,000 | +49.2% | 2,003,688 | +37.8% | 0.45% | +36.6% |
| Q4 2020 | $20,515,000 | +49.6% | 1,453,966 | +66.2% | 0.33% | +17.8% |
| Q3 2020 | $13,709,000 | -11.8% | 874,842 | -1.3% | 0.28% | -25.7% |
| Q2 2020 | $15,536,000 | – | 886,762 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,030,616 | $31,028,000 | 6.04% |
| 5AM Venture Management, LLC | 1,362,286 | $20,816,000 | 3.75% |
| Burrage Capital Management LLC | 272,393 | $4,162,000 | 3.37% |
| Altium Capital Management LP | 361,930 | $5,530,000 | 1.54% |
| Vivo Capital, LLC | 2,214,138 | $33,832,000 | 1.19% |
| Bain Capital Life Sciences Investors, LLC | 1,071,428 | $16,371,000 | 0.93% |
| Perceptive Advisors | 3,659,381 | $51,606,000 | 0.65% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,154,000 | 0.50% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,003,688 | $30,616,000 | 0.45% |
| Opaleye Management Inc. | 188,000 | $2,873,000 | 0.42% |